TCUPS- Tolvaptan Use in Cystinuria and Urolithiasis: A Pilot Study

Summary

The goal of this research project is to establish that in short-term use, tolvaptan is a safe and potentially effective new therapy for cystinuria, by conducting a short-term pilot study of the safety and tolerability of this drug, and assess impact on urinary stone risk parameters, among adolescent and young adult patients with clinical cystinuria.

Timeline

Start

2016-10

Primary completion

2018-12

Completion

2018-12

Drugs

Indications